Fatty liver disease, particularly Non-Alcoholic Fatty Liver Disease (NAFLD), is a growing health concern worldwide, affecting an estimated 30.2% of the world's population. Prevalence varies by region, ...
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...
The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...
The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...
NASH, has received FDA approval to revolutionize liver disease drug trials. This innovative technology assists pathologi ...
What makes fatty liver even more worrying is that it often develops without any signs. Most people don’t know they have it ...
Gleneagles Hospital, Parel, Mumbai, one of India’s leading centres for liver care and transplantation, has achieved a major ...
One fast-rising biotech just landed a heavyweight backer ahead of a pivotal presentation—here’s what investors should watch.
Obesity is the excessive or abnormal accumulation of fat or adipose tissue in the body that impairs health via its ...
If you’re in menopause, you may be more likely to get new health problems because of changes that happen when your body stops producing estrogen. One of these health problems can be nonalcoholic fatty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback